The value of magnetic resonance imaging (MRI) in helping clinicians to better assess the size and extent of known breast cancers is well established. However, the use of MRI as a screening tool in women at high risk of breast cancer is now on the increase as well, particularly since April when the American Cancer Society (ACS) unveiled guidelines recommending the use of MRI as a screening tool in this subset of women.